Search For "sanofi"
DCGI issues advisory to states/UTs medical professionals on theft of insul
Updated : 1 week, 3 days ago IST
The DCGI (Drugs Controller General of India) on Wednesday issued an alert regarding a stolen batch of Sanofi India's insulin formulation, Lantus SoloStar (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL), with batch number 5F0347B.
Read More
WeThinkNorth Emerges as Digital Growth Partner for Wipro, Sanofi and Risin
Updated : 1 year, 4 months ago IST
Noida (Uttar Pradesh) [India], November 7: WeThinkNorth, a leading digital marketing, branding, and social media agency in India, is becoming the partner of choice for brands seeking impactful and strategic digital marketing solutions. The agency is establishing new standards in brand presen
Read More
"Working towards resuming supplies...": Sanofi on Allegra, Combiflam suspe
Updated : 1 year, 8 months ago IST
After Sanofi issued a circular to all pharma distributors, hospitals and retailers in the Indian market regarding a "temporary halt" of sales of its Allegra Suspension syrup and Combiflam Suspension, French multinational pharma company Sanofi on Monday said that the company is working toward
Read More
Sanofi initiates voluntary recall of Allegra, Combiflam suspensions due to
Updated : 1 year, 8 months ago IST
The French Multinational Pharmaceutical and Healthcare company Sanofi Consumer Healthcare India Ltd has issued circular to all pharma distributors, hospitals and retailers regarding temporary stoppage of sales as precautionary voluntary recall of Allegra Suspension (Fexofenadine Hydrochlo
Read More
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centr
Updated : 2 years ago IST
Singapore, February 29: Medidata, a Dassault Systemes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies. This builds on Medidata and Sanofi's longs
Read More
"It is very complicated": Usher opens up about son suffering from Type 1 d
Updated : 2 years, 4 months ago IST
Usher, who is partnering with Sanofi to raise awareness about Type 1 diabetes testing, opened up about his co-parenting experience, People reported.
Read More
Sanofi cuts insulin prices by up to 78 pc
Updated : 3 years ago IST
Sanofi plans to take a 78 per cent list-price reduction on Lantus, the company's most widely used insulin in the US, and a 70 per cent cut on its Apidra product starting in January 2024, the company said.
Read More
Vistaar Finance is the Best Mid-Size Financial Services Company to work fo
Updated : 4 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 30 (ANI/BusinessWire India): Vistaar Finance has been named the Best Mid-Sized Financial Services Company to work for in India, according to the 2021 rankings from AmbitionBox. Vistaar has also secured the 13th spot in the list of India's 25 Best Mid-Sized
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 8 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
US to lift Defense Production Act ratings on AstraZeneca, Novavax, Sanofi
Updated : 4 years, 9 months ago IST
Washington [US], June 4 (ANI): White House COVID-19 response coordinator Jeff Zients said on Thursday that the US will lift Defense Production Act ratings on the AstraZeneca, Novavax, and Sanofi COVID vaccines.
Read More
Mexico to conduct clinical trials of Walvax, Sanofi Vaccines: Foreign Secr
Updated : 4 years, 10 months ago IST
Mexico City [Mexico], May 25 (ANI/Sputnik): Mexico intends to conduct clinical trials of vaccines against COVID-19 developed by China's Walvax and France's Sanofi, Foreign Secretary Marcelo Ebrard said.
Read More
Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could b
Updated : 5 years, 1 month ago IST
Paris [France], February 22 (ANI): Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of their COVID-19 vaccine candidates, and if results are positive, a phase 3 study could start in the second quarter of 2021.
Read More